Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 4;32(9):2930-2938.
doi: 10.1016/j.ymthe.2024.06.003. Epub 2024 Jun 6.

Biomarkers for gene therapy clinical trials of lysosomal storage disorders

Alessandro Rossi  1 , Sabrina Malvagia  2 , Giancarlo la Marca  3 , Giancarlo Parenti  4 , Nicola Brunetti-Pierri  5
Affiliations
Review

Biomarkers for gene therapy clinical trials of lysosomal storage disorders

Alessandro Rossi et al. Mol Ther. .

Abstract

Lysosomal storage disorders (LSDs) are multisystemic progressive disorders caused by defects in proteins involved in lysosomal function. Different gene therapy strategies are under clinical investigation in several LSDs to overcome the limitations of available treatments. However, LSDs are slowly progressive diseases that require long-term studies to establish the efficacy of experimental treatments. Biomarkers can be reliable substitutes for clinical responses and improve the efficiency of clinical trials, especially when long-term disease interventions are evaluated. In this review, we summarize both available and future biomarkers for LSDs and discuss their strengths and weaknesses.

Keywords: biomarker; gene therapy; lysosomal storage disorders.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Walsh S., Merrick R., Richard E., Nurock S., Brayne C. Lecanemab for Alzheimer's disease. BMJ. 2022;379:o3010. doi: 10.1136/bmj.o3010. - DOI - PubMed
    1. Robb M.A., McInnes P.M., Califf R.M. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. JAMA. 2016;315:1107–1108. doi: 10.1001/jama.2016.2240. - DOI - PubMed
    1. Califf R.M. Biomarker definitions and their applications. Exp. Biol. Med. 2018;243:213–221. doi: 10.1177/1535370217750088. - DOI - PMC - PubMed
    1. Konus O.L., Ozdemir A., Akkaya A., Erbas G., Celik H., Isik S. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am. J. Roentgenol. 1998;171:1693–1698. doi: 10.2214/ajr.171.6.9843315. - DOI - PubMed
    1. Fetzer D.T., Browning T., Xi Y., Yokoo T., Singal A.G. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations. AJR Am. J. Roentgenol. 2022;218:1010–1020. doi: 10.2214/AJR.21.26735. - DOI - PMC - PubMed

LinkOut - more resources